TABLE OF CONTENT: 1.Introduction 1.1. Research Scope 1.2. Market Segmentation 1.3. Research Methodology 1.4. Definitions and Assumptions 2.Executive Summary 3.Market Dynamics 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4.Key Insights 4.1 Key strategies of leading market players 4.2 Technological advancements 4.3 Key mergers and acquisitions 4.4 Key performance indicators 5.Global Hemostatic Agents Market Analysis, Insights and Forecast, 2014-2025 5.1. Key Findings/ Summary 5.2. Market Analysis,Insights and Forecast – By Application 5.2.1Trauma 5.2.2Cardiovascular Surgery 5.2.3General Surgery 5.2.4Plastic Surgery 5.2.5Orthopedic Surgery 5.2.6Neurosurgery 5.2.7 Others 5.3. Market Analysis, Insights and Forecast – By Product 5.3.1Active Hemostats 5.3.1.1Thrombin based Hemostats 5.3.1.2Fibrin Sealants 5.3.2Passive Hemostats 5.3.2.1Plant-based Hemostats 5.3.2.2Animal-based Hemostats 5.3.2.3Others 5.3.3Combination Hemostats 5.3.4Others 5.4. Market Analysis, Insights and Forecast – By End User 5.4.1Hospitals 5.4.2Ambulatory Surgical Centers 5.4.3Tactical Combat Casualty Care Centers 5.4.4Others 5.5. Market Analysis, Insights and Forecast – By Region 5.5.1North America 5.5.2Europe 5.5.3Asia Pacific 5.5.4Latin America 5.5.5Middle East and Africa 6.North America Hemostatic Agents Market Analysis, Insights and Forecast,2014-2025 6.1. Key Findings/ Summary 6.2. Market Analysis – By Application 6.2.1Trauma 6.2.2Cardiovascular Surgery 6.2.3General Surgery 6.2.4Plastic Surgery 6.2.5Orthopedic Surgery 6.2.6Neurosurgery 6.2.7Others 6.3. Market Analysis – By Product 6.3.1Active Hemostats 6.3.1.1Thrombin based Hemostats 6.3.1.2Fibrin Sealants 6.3.2Passive Hemostats 6.3.2.1Plant-based Hemostats 6.3.2.2Animal-based Hemostats 6.3.2.3Others 6.3.3Combination Hemostats 6.3.4Others 6.4. Market Analysis – By End User 6.4.1Hospitals 6.4.2Ambulatory Surgical Centers 6.4.3Tactical Combat Casualty Care Centers 6.4.4Others 6.5. Market Analysis – By Country 6.5.1US 6.5.2Canada 7.Europe Hemostatic Agents Market Analysis, Insights and Forecast, 2014-2025 7.1. Key Findings/ Summary 7.2. Market Analysis – By Application 7.2.1Trauma 7.2.2Cardiovascular Surgery 7.2.3General Surgery 7.2.4Plastic Surgery 7.2.5Orthopedic Surgery 7.2.6Neurosurgery 7.2.7Others 7.3. Market Analysis – By Product 7.3.1Active Hemostats 7.3.1.1Thrombin based Hemostats 7.3.1.2Fibrin Sealants 7.3.2Passive Hemostats 7.3.2.1Plant-based Hemostats 7.3.2.2Animal-based Hemostats 7.3.2.3Others 7.3.3Combination Hemostats 7.3.4Others 7.4. Market Analysis – By End User 7.4.1Hospitals 7.4.2Ambulatory Surgical Centers 7.4.3Tactical Combat Casualty Care Centers 7.4.4Others 7.5. Market Analysis – By Country 7.5.1UK 7.5.2Germany 7.5.3France 7.5.4Italy 7.5.5Spain 7.5.6Scandinavia 7.5.7Rest of Europe 8.Asia Pacific Hemostatic Agents Market Analysis, Insights and Forecast,2014-2025 8.1. Key Findings/ Summary 8.2. Market Analysis – By Application 8.2.1Trauma 8.2.2Cardiovascular Surgery 8.2.3General Surgery 8.2.4Plastic Surgery 8.2.5Orthopedic Surgery 8.2.6Neurosurgery 8.2.7Others 8.3. Market Analysis – By Product 8.3.1Active Hemostats 8.3.1.1Thrombin based Hemostats 8.3.1.2Fibrin Sealants 8.3.2Passive Hemostats 8.3.2.1Plant-based Hemostats 8.3.2.2Animal-based Hemostats 8.3.2.3Others 8.3.3Combination Hemostats 8.3.4Others 8.4. Market Analysis – By End User 8.4.1Hospitals 8.4.2Ambulatory Surgical Centers 8.4.3Tactical Combat Casualty Care Centers 8.4.4Others 8.5. Market Analysis – By Country 8.5.1Japan 8.5.2China 8.5.3India 8.5.4Australia & New Zealand 8.5.5South East Asia 8.5.6Rest of Asia pacific 9.Latin America Hemostatic Agents Market Analysis, Insights and Forecast,2014-2025 9.1. Key Findings/ Summary 9.2. Market Analysis – By Application 9.2.1Trauma 9.2.2Cardiovascular Surgery 9.2.3General Surgery 9.2.4Plastic Surgery 9.2.5Orthopedic Surgery 9.2.6Neurosurgery 9.2.7Others 9.3. Market Analysis – By Product 9.3.1Active Hemostats 9.3.1.1Thrombin based Hemostats 9.3.1.2Fibrin Sealants 9.3.2Passive Hemostats 9.3.2.1Plant-based Hemostats 9.3.2.2Animal-based Hemostats 9.3.2.3Others 9.3.3Combination Hemostats 9.3.4Others 9.4. Market Analysis – By End User 9.4.1Hospitals 9.4.2Ambulatory Surgical Centers 9.4.3Tactical Combat Casualty Care Centers 9.4.4Others 9.5. Market Analysis – By Country 9.5.1Brazil 9.5.2Mexico 9.5.3Rest of Latin America 10.Middle East and Africa Hemostatic Agents Market Analysis, Insights and Forecast,2014-2025 10.1. Key Findings/ Summary 10.2. Market Analysis – By Application 10.2.1Trauma 10.2.2Cardiovascular Surgery 10.2.3General Surgery 10.2.4Plastic Surgery 10.2.5Orthopedic Surgery 10.2.6Neurosurgery 10.2.7Others 10.3. Market Analysis – By Product 10.3.1Active Hemostats 10.3.1.1Thrombin based Hemostats 10.3.1.2Fibrin Sealants 10.3.2Passive Hemostats 10.3.2.1Plant-based Hemostats 10.3.2.2Animal-based Hemostats 10.3.2.3Others 10.3.3Combination Hemostats 10.3.4Others 10.4. Market Analysis– By End User 10.4.1Hospitals 10.4.2Ambulatory Surgical Centers 10.4.3Tactical Combat Casualty Care Centers 10.4.4Others 10.5. Market Analysis – By Country 10.5.1GCC 10.5.2South Africa 10.5.3Rest of Middle East & Africa 11.Competitive Analysis 11.1. Key Industry Developments 11.2. Global Market Share Analysis (2017) 11.3. Competition Dashboard 11.4. Comparative Analysis – Major Players 11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability)) 11.5.1Baxter International Inc. 11.5.2Integra Life Sciences 11.5.3Stryker 11.5.4CryoLife Inc. 11.5.5BD 11.5.6Ethicon LLC. 11.5.7Pfizer Inc. 11.5.8Medtronic 11.5.9Biom’up 11.5.10Others 12.Strategic Recommendations

Baxter International Inc. Stryker CryoLife Inc. Integra Life Sciences BD Ethicon LLC. Pfizer Inc. Medtronic Biom’up Other players